Mitaka USA, Inc.   Report issue

For profit
Founded: Denver CO United States (1996)
Status: No NME R&D (1996)

Organization Overview

First Clinical Trial
2015
NCT02419807
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2